Results 191 to 200 of about 7,741 (242)
Some of the next articles are maybe not open access.
Color Doppler Ultrasound Assessment of Subclinical Activity With Scoring of Morphea
Journal of Cutaneous Medicine and Surgery, 2023Background Detection of activity in morphea is paramount for adequately managing the disease. Subclinical ultrasound involvement on inactive lesions or healthy skin areas adjacent to morphea has not been described to date.
Julio Parra-Cares +5 more
semanticscholar +1 more source
Immunologic underpinnings and treatment of morphea
Expert Review of Clinical Immunology, 2022Introduction Morphea is a chronic autoimmune fibrosing condition of the skin and underlying tissue with the potential for significant disease-associated morbidity.
Avery H Lachance +2 more
exaly +2 more sources
Journal of Biophotonics, 2023
This paper describes a methodology to differentiate morphea from lichen sclerosus based on examination with multiphoton microscopy (MPM) composed of two-photon excited fluorescence (TPEF) and second harmonic generation (SHG).
Qianqiong Wang +6 more
semanticscholar +1 more source
This paper describes a methodology to differentiate morphea from lichen sclerosus based on examination with multiphoton microscopy (MPM) composed of two-photon excited fluorescence (TPEF) and second harmonic generation (SHG).
Qianqiong Wang +6 more
semanticscholar +1 more source
Journal of the American Academy of Dermatology, 2003
The superficial variant of morphea is a recently described entity that differs in its clinical and histologic presentation from classic morphea. The condition has been reported only in females to date and is characterized by minimal to no induration and hypopigmented or hyperpigmented patches without associated symptoms, systemic involvement ...
Laurie, Jacobson +2 more
openaire +2 more sources
The superficial variant of morphea is a recently described entity that differs in its clinical and histologic presentation from classic morphea. The condition has been reported only in females to date and is characterized by minimal to no induration and hypopigmented or hyperpigmented patches without associated symptoms, systemic involvement ...
Laurie, Jacobson +2 more
openaire +2 more sources
A case of morphea following the COVID‐19 mRNA vaccine: on the basis of viral spike proteins
International Journal of Dermatology, 2022Dear Editor, Pfizer-BioNTech (BNT162b2) is a COVID-19 vaccine that contains synthetic mRNA to make the body produce a copy of viral spike protein of the SARS-CoV-2. The immune system reacts to these spike proteins by producing antibodies and memory cells.
Zuhal Metin, P. Celepli
semanticscholar +1 more source
Ophthalmology, 1982
Morphea, or localized scleroderma, of the eyelids is an uncommon disease. Morphea usually involves the thorax, trunk, lower and upper extremities, face, and genitalia. In the present report a patient with a biopsy-proven morphea of both upper eyelids is described.
F, El-Baba +4 more
openaire +2 more sources
Morphea, or localized scleroderma, of the eyelids is an uncommon disease. Morphea usually involves the thorax, trunk, lower and upper extremities, face, and genitalia. In the present report a patient with a biopsy-proven morphea of both upper eyelids is described.
F, El-Baba +4 more
openaire +2 more sources
Bullous lichen sclerosus–generalized morphea overlap syndrome improved by tofacitinib
Dermatologic Therapy, 2022We here report a case of a middle‐aged man with an unusual case of bullous lichen sclerosus complicated with generalized morphea. He showed initial recurrent flaccid bullae, followed by ivory‐white sclerotic plaques and extensive skin sclerosis, with ...
Licong Liu +10 more
semanticscholar +1 more source
The value of dermoscopy and high‐frequency ultrasound in staging morphea
Journal of dermatology (Print), 2022Morphea is an autoimmune disease characterized by skin sclerosis. According to the disease progression, morphea can be divided into inflammatory, sclerotic, and atrophic stages.
Shan-xing Zhang +3 more
semanticscholar +1 more source
Dermatology, 2008
Scleroderma may present as being strictly limited to the skin, as in morphea, or within a multiorgan disease, as in systemic sclerosis. Accordingly, cutaneous manifestations vary clinically. In nodular or keloidal scleroderma, patients develop lesions that are clinically indistinguishable from a keloid; however, the histopathological findings are more ...
F, Kauer, J C, Simon, M, Sticherling
openaire +2 more sources
Scleroderma may present as being strictly limited to the skin, as in morphea, or within a multiorgan disease, as in systemic sclerosis. Accordingly, cutaneous manifestations vary clinically. In nodular or keloidal scleroderma, patients develop lesions that are clinically indistinguishable from a keloid; however, the histopathological findings are more ...
F, Kauer, J C, Simon, M, Sticherling
openaire +2 more sources
Pediatric morphea state‐of‐the‐art literature review: Reframing morphea as a systemic disease
Pediatric Dermatology, 2021Pediatric morphea is an inflammatory, fibrosing dermatologic disorder. Although morphea may be localized to the skin and subcutaneous tissues, differentiating it from systemic sclerosis, there is increasing evidence that morphea is a manifestation of a ...
Jacquelyn R Sink, Yvonne E Chiu
exaly +2 more sources

